NEW RESEARCH IN AIR QUALITY HEALTH

GOAL

Update participants about recent research in air quality and health.

DESCRIPTION

This presentation will give an update on the most recent research on the human health effects of air pollution, including recent work from the H. Kim Lyerly and Julia Kravchenko.

Keynote Speakers

JULIA KRAVCHENKO, M.D., PH.D.

JULIA KRAVCHENKO, M.D., PH.D.

Assistant Professor of Surgery

Duke University

Dr. Julia Kravchenko, MD, Ph.D. is an Assistant Professor in the Division of Surgical Sciences, Department of Surgery, Duke University School of Medicine. Her area of research interests includes population-based studies of health outcome, analysis of health impacts of environmental exposures on disease risk and patients’ survival, including the studies on the effects of water quality, air pollution, and weather/extreme temperatures on human health. She also does Medicare based and Medicare-linked large health data analysis of cancer and chronic non-cancer disease incidence, progression, treatment effectiveness, and survival among the older U.S. adults, as well studies the role of comorbidities in cancer patients in treatment choice and patients’ survival.

H. Kim Lyerly, M.D.

H. Kim Lyerly, M.D.

George Barth Geller Professor of Research in Cancer Professor of Surgery and Immunology Associate Professor of Pathology Director of Surgical Science and Applied Therapeutics Section

Duke University

Kim Lyerly, MD, FACS is the George Barth Geller Professor of Cancer Research, Professor of Surgery, Associate Professor of Pathology and Assistant Professor of Immunology at Duke University in North Carolina. He was appointed in 2008 by US President George Bush to serve a six-year term on the National Cancer Advisory Board, which oversees the US National Cancer Institute. He served as Chair of the Cancer Centers Sub Committee and on the Global Health Sub-Committee of the National Cancer Advisory Board. He has also served on the National Institute of Health Council of Councils, and the Board of the National Institute of Health Office of AIDS Research. He has been a member of the Scientific Advisory Board of the Susan G. Komen for the Cure Foundation and the Burroughs Wellcome Foundation. Dr. Lyerly is a highly sought after consultant and advisor and has served on the Cancer Centers external advisory boards for MD Anderson, University of Michigan, University of Chicago, University of Alabama, University of Arizona, Boston University, and Purdue. He has served as an advisor to the University of Washington, and Case Western Reserve Clinical and Translational Science Institutes.

Dr. Lyerly has been actively involved in cancer research and education internationally for over 10 years. He has research collaborations in cancer care, cancer immunotherapy, and cancer genomics with faculty members in China, India and Pakistan. He has been a faculty member of the Medical Oncology Group of Australia Clinical Trials Workshop, and has conducted clinical trials workshops in Singapore, China, India, Nepal and Pakistan. He currently leads a workshop with the US Food and Drug Administration directed to accelerating entry in the markets for cancer treatment.